Volume 83, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



In the United States, multidrug-resistant tuberculosis (MDR-TB) is more commonly seen among foreign-born patients. We report outcomes for 46 patients with MDR-TB who were born in Mexico and treated along the United States–Mexico border. According to our definition, 30 were cured, 3 showed treatment failure, 3 died, and 10 abandoned treatment. Multidrug-resistant tuberculosis can be successfully treated on an ambulatory basis.


Article metrics loading...

Loading full text...

Full text loading...



  1. Cain KP, Benot SR, Winston CA, MacKenzie WR, , 2008. Tuberculosis among foreign-born persons in the United States. JAMA 300: 405412.[Crossref]
  2. Tuberculosis along the US–Mexico Border Work Group, Centers for Disease Control and Prevention, 2001. Preventing and controlling tuberculosis in the US–Mexico border. MMWR Recomm Rep 50: 127.
  3. Migliori GB, D'Arcy Richardson M, Sotgiu G, Lange C, , 2009. Multidrug-resistant and extensively drug-resistant tuberculosis in the west Europe and United States: epidemiology, surveillance and control. Clin Chest Med 30: 637665.[Crossref]
  4. Zazueta-Beltran J, Leon-Sicarios C, Canizales-Roman A, , 2009. Drug resistant Mycobacterium tuberculosis in Mexico. J Infect Dev Ctries 30: 162168.
  5. American Thoracic Society/Center for Disease Control and Prevention/Infectious Diseases Society of America, 2003. Treatment of tuberculosis. Am J Respir Crit Care Med 167: 603662.[Crossref]
  6. Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, Zarovska E, Rich ML, Fraser HS, Alarcón E, Cegileski JP, Grzemska M, Gupta R, Espinal M, , 2003. Speaking the same language: treatment outcomes definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 9: 640645.
  7. Goble M, Iseman M, Madsen LA, Waite D, Ackerson L, Horsburgh CR, Jr, 1993. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 328: 527532.[Crossref]
  8. Burgos M, Gonzales LC, Paz EA, Gournis E, Kawamura LM, Schecter G, Hopewell PC, Daley CL, , 2005. Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient based approach. Clin Infect Dis 40: 968975.[Crossref]
  9. Munsiff SS, Ahuja SD, Li J, Driver CR, , 2006. Public-private collaboration for multidrug-resistant tuberculosis control in New York City. Int J Tuberc Lung Dis 10: 639648.
  10. Narita M, Alonso P, Lauzardo M, , 2001. Treatment experience of multidrug-resistant tuberculosis in Florida, 1994–1997. Chest 120: 343348.[Crossref]
  11. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcántara F, Sánchez E, Sarria M, Becerra M, Fawzi MC, Kapiga S, Neuberg D, Maguire JH, Kim JY, Farmer P, , 2003. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 348: 119128.[Crossref]
  12. Chan ED, Laurel V, Strand MJ, Strand MJ, Chan JF, Huynh ML, Goble M, Iseman MD, , 2004. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 169: 11031109.[Crossref]
  13. World Health Organization, 2006. Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. Geneva: World Health Organization, WHO/TB/96.210.
  14. Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Glavani AP, , 2009. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis 9: 153161.[Crossref]

Data & Media loading...

  • Received : 04 Mar 2010
  • Accepted : 14 May 2010

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error